Login to Your Account

Facet Biotech Wooed by $722M Acquisition Offer from Abbott

By Trista Morrison

Thursday, March 11, 2010
Three months after Biogen Idec Inc. failed to acquire Facet Biotech Corp. for $17.50 per share, Abbott is getting the job done with a $27-per-share offer. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription